Nocturia in Parkinson's Disease: Why Does It Occur and How to Manage?

被引:31
|
作者
Batla, Amit [1 ]
Phe, Veronique [2 ,3 ,4 ]
De Min, Lorenzo [2 ,3 ]
Panicker, Jalesh N. [2 ,3 ]
机构
[1] UCL Inst Neurol, Dept Motor Neurosci & Movement Disorders, 7 Queen Sq, London WC1N 3BG, England
[2] Natl Hosp Neurol & Neurosurg, Dept Uroneurol, London, England
[3] UCL Inst Neurol, London, England
[4] Univ Paris 06, Pitie Salpetriere Acad Hosp, AP HP, Pierre & Marie Curie Med Sch,Dept Urol, Paris, France
来源
MOVEMENT DISORDERS CLINICAL PRACTICE | 2016年 / 3卷 / 05期
关键词
nocturia; Parkinson's disease; uro-neurology;
D O I
10.1002/mdc3.12374
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundNocturia is one of the commonest nonmotor symptoms in Parkinson's disease (PD) and has a significant impact on quality of life both for patients and their carers. There exists a relation between nocturia and poor sleep quality, falls, and institutionalization. Nocturia may manifest as a result of reduced functional bladder capacity or nocturnal polyuria; however, most often the cause is multifactorial. Disorders of circadian rhythm regulation are known to occur with sleep disturbances in PD may also contribute to nocturia. Methods and ResultsIn this review, an overview of the assessment and management of nocturia in patients with PD is presented. History taking, medication review, and a bladder diary form the cornerstone of the evaluation. Urinalysis, ultrasonography, and urodynamic studies help to assess the cause for lower urinary tract symptoms and exclude concomitant pathologies, such as bladder outlet obstruction. Antimuscarinic medications are the first-line treatment for the overactive bladder; however, caution is needed when using these medications in individuals predisposed to cognitive impairment. Desmopressin is effective for managing nocturnal polyuria. ConclusionsAn individualized approach is recommended to optimize the management of nocturia in PD.
引用
收藏
页码:443 / 451
页数:9
相关论文
共 50 条
  • [3] Epidemiology of disabling neurological disease: How and why does disability occur?
    Wade, DT
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 61 (03): : 242 - 249
  • [4] Epidemiology of disabling neurological disease: how and why does disability occur?
    Wade, DT
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 : S11 - S18
  • [5] Apoptosis: why and how does it occur in biology?
    Ulukaya, Engin
    Acilan, Ceyda
    Yilmaz, Yusuf
    CELL BIOCHEMISTRY AND FUNCTION, 2011, 29 (06) : 468 - 480
  • [6] How common is comorbidity and why does it occur?
    Teesson, M
    Degenhardt, L
    Proudfoot, H
    Hall, W
    Lynskey, M
    AUSTRALIAN PSYCHOLOGIST, 2005, 40 (02) : 81 - 87
  • [7] Nocturia and Sleep in Parkinson's Disease
    Diaconu, Stefania
    Irincu, Laura
    Ungureanu, Larisa
    Tint, Diana
    Falup-Pecurariu, Cristian
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (07):
  • [8] Nocturia in Patients With Parkinson's Disease
    Smith, Matthew
    Seth, Jai
    Batla, Amit
    Hofereiter, Johann
    Bhatia, Kailash P.
    Panicker, Jalesh N.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2016, 3 (02): : 168 - 172
  • [9] How to manage daytime sleepiness associated with Parkinson's disease
    De Cock, V. Cochen
    Dauvilliers, Y.
    REVUE NEUROLOGIQUE, 2010, 166 (10) : 793 - 799
  • [10] Anaesthesia and Parkinson's disease: how to manage with new therapies?
    Kalenka, Armin
    Schwarz, Anke
    CURRENT OPINION IN ANESTHESIOLOGY, 2009, 22 (03) : 419 - 424